• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bold Secures $17M to Expand Healthy Aging Platform with Medicare Plans

by Fred Pennic 09/12/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

  • Bold, a Los Angeles-based healthy aging platform raises $17M in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The latest funding, bringing its total amount raised to $27M. 
  • The company plans to utilize the capital to support Bold’s continued expansion with national and regional Medicare plans and provider groups, and accelerate the growth of its clinical exercise offerings to support the diverse physical and mental health needs of older adults.

Reduce falls, increase activity, improve satisfaction

1 in 3 adults over 65 falls every year. Founded in 2020, Bold provides each member with a personalized, evidence-based exercise program in order to prevent falls, reduce musculoskeletal pain and disability, and increase physical activity levels. The company partners with innovative Medicare plans and providers to support underserved members, many of whom suffer from chronic conditions, mobility issues, and pain. Utilizing dynamic adjustments and sophisticated behavioral science, Bold’s platform engages members continuously as they build sustainable habits that provide lasting impact.

Bold’s Program Peer-Reviewed Research

In peer-reviewed research, Bold’s programs have demonstrated a 46% reduction in falls, which impact more than one in four Americans over the age of 65 each year and result in $50 billion in costs, more than Medicare’s annual spend on cancer. With less than 15 percent of older adults in the U.S. meeting recommended physical activity guidelines, evidence is widespread that Bold’s pioneering, movement-as-medicine approach can provide durable, cost-effective healthspan improvements for older adults. According to the CDC, 4 out of 5 of the most costly chronic conditions among adults 50 years or older can be prevented or managed with physical activity, and Bold will use this funding to accelerate its impact on these costly conditions within its healthy aging platform.

“Millions of older adults spend years in poor and declining health brought on by falls, pain, and other chronic conditions, representing a growing disconnect between quality of life and overall longevity,” said Amanda Rees, Co-founder and CEO of Bold. “Bold was designed to increase healthspan for older adults, offering accessible, easy-to-follow programs that improve strength, reduce falls, and promote lifelong well-being.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Aging Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |